| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CEO & President | President & COO
1 company
Danny Prosky is Director at AHR. From May 2017 to July 2026, the filings on record show 43 open-market purchases and 0 sales. Danny Prosky's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $17.6M at current prices.
Net of sales, the AHR filings show accumulation of 218,983 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2017 | AHR American Healthcare Reit, Inc. | President & COO | Buy | 1,213 | $9.21 | $11,171.73 | +11.8% | |
| May 22, 2017 | AHR American Healthcare Reit, Inc. | President & COO | Buy | 1,229 | $9.21 | $11,319.09 | +13.6% | |
| May 5, 2017 | AHR American Healthcare Reit, Inc. | President & COO | Buy | 1,233 | $9.21 | $11,355.93 | +15.8% |